ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000227014.1	ABT-263 (navitoclax)	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.042430665	Resistant
ENSG00000227014.1	ABT-263 (navitoclax)	Brain lower grade glioma	0.018411583	Resistant